arthritis: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1751 |
4. Check minimum number of eventsNone |
1751 |
5. Include endpointsNone |
1751 |
6. Filter based on genotype QC (FinnGen only) |
1751 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M13
- Name in latin
- Monoarthritis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Monoarthritis, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other arthritis (FG)
- Polyarthropathies
- Finngen Rheumatological endpoints
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13581 | 7027 | 6469 |
| Only index persons | 11719 | 6178 | 5541 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.19 | 0.20 | 0.18 |
| Only index persons | 0.22 | 0.23 | 0.21 |
| Median age at first event (years) | |||
| Whole population | 42.99 | 45.65 | 39.95 |
| Only index persons | 40.21 | 43.14 | 36.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1751 | 995 | 756 |
| Unadjusted period prevalence (%) | 0.34 | 0.34 | 0.33 |
| Median age at first event (years) | 45.16 | 42.22 | 49.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1592
- Matched controls
- 15919
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
35.4
323.0
440
170
A07EC01
ATC
sulfasalazine; oral, rectal
36.0
323.0
438
166
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
83.5
323.0
392
62
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
32.3
323.0
559
262
M13.9
ICD-10 Finland
Arthritis, unspecified
71.5
323.0
460
90
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
3003.4
323.0
1144
13
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
58.8
301.4
354
77
P01BA02
ATC
hydroxychloroquine; oral
31.6
278.3
376
154
M17.1
ICD-10 Finland
Other primary gonarthrosis
22.5
231.0
346
194
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1133.8
208.1
199
*
M25.5
ICD-10 Finland
Pain in joint
6.6
192.8
592
1308
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
160.1
151
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
52.9
152.6
183
39
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
84.3
143.5
160
21
H02AB06
ATC
prednisolone; systemic
3.8
135.3
920
4220
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
14.1
133.8
238
196
7166A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified monoarthritis
+∞
131.0
124
*
71105
ICD-8 Finland
Acute nonpyogenic arthritis, Genus
+∞
128.9
122
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
78.8
127.9
144
20
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
75.1
127.1
144
21
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
651.7
124.0
121
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
15.6
123.1
209
153
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
225.7
122.6
125
6
M19.0
ICD-10 Finland
Primary arthrosis of other joints
28.3
116.7
161
63
M16.1
ICD-10 Finland
Other primary coxarthrosis
34.1
115.7
152
49
L88
ICPC
Rheumatoid/seropositive arthritis
37.9
108.5
139
40
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
170.2
106.7
111
7
L04AA13
ATC
leflunomide; oral
148.9
105.5
111
8
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
30.2
96.9
131
47
71104
ICD-8 Finland
Acute nonpyogenic arthritis, Coxae
+∞
94.7
90
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
107.7
93.1
101
10
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
32.9
92.2
122
40
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
7.7
87.8
216
316
NF1AA
NOMESCO Finland
Hip X-ray examination
11.3
86.6
169
165
M01AH05
ATC
etoricoxib; oral
2.8
82.2
959
5600
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
795.5
78.0
76
*
N02AX02
ATC
tramadol; systemic, rectal
2.8
75.1
694
3449
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
9.1
73.1
160
192
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
740.5
72.7
71
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
7.9
72.5
175
246
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
69.7
719
3766
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
7.6
69.2
171
249
M10.9
ICD-10 Finland
Gout, unspecified
11.5
68.6
132
124
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
79.8
67.7
76
10
M13.0
ICD-10 Finland
Polyarthritis, unspecified
96.9
67.5
74
8
N02BE01
ATC
paracetamol; systemic, rectal
3.1
65.6
1360
10418
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
653.3
64.3
63
*
M01AC06
ATC
meloxicam; systemic, rectal
2.7
63.5
602
2960
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
20.0
63.0
96
51
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
62.9
729
4007
L15
ICPC
Knee symptom/complaint
3.6
62.4
319
1029
L04AB01
ATC
etanercept; parenteral
88.8
61.4
68
8
M01AX05
ATC
glucosamine; oral
4.1
61.0
263
731
M79.6
ICD-10 Finland
Pain in limb
2.6
60.9
576
2813
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
60.4
598
2992
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
112.8
60.3
65
6
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
313.8
59.7
60
*
TNG10
NOMESCO Finland
Puncture of knee
161.1
59.3
62
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
56.2
59.3
70
13
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
56.6
54
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
153.0
56.2
59
*
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
25.6
55.5
78
32
B01AB05
ATC
enoxaparin; parenteral
2.7
54.6
464
2103
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
71.4
54.5
62
9
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
120.2
54.2
58
5
M01CB01
ATC
sodium aurothiomalate; parenteral
545.5
53.8
53
*
L04AB04
ATC
adalimumab; parenteral
23.5
50.1
72
32
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
49.7
513
2568
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
72.3
49.4
56
8
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
36.4
49.1
63
18
A02BC02
ATC
pantoprazole; systemic
2.2
49.1
991
6810
M04AA01
ATC
allopurinol; systemic
4.0
48.4
211
585
NH3EA
NOMESCO Finland
Feet X-ray examination with load
49.1
47.3
57
12
NG1DA
NOMESCO Finland
X-ray of knees
55.8
45.8
54
10
L40.5
ICD-10 Finland
Arthropathic psoriasis
123.6
45.0
48
*
M13.8
ICD-10 Finland
Other specified arthritis
65.7
44.4
51
8
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
231.2
44.1
45
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.5
44.0
119
195
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
12.9
44.0
79
64
71106
ICD-8 Finland
Acute nonpyogenic arthritis, Talocruralis sive pedis
+∞
43.9
42
*
M01AH01
ATC
celecoxib; oral (coxibs)
3.0
43.2
279
1045
S18
ICPC
Laceration/cut
2.2
41.5
607
3527
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.2
41.2
135
280
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
5.0
41.1
139
299
M01AE02
ATC
naproxen; oral, rectal
2.0
40.6
872
5929
WX320
NOMESCO Finland
Spinalanesthesy
2.8
39.5
296
1215
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
10.1
39.0
79
82
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
51.3
37.7
45
9
M07.3
ICD-10 Finland
Other psoriatic arthropathies
+∞
37.6
36
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
+∞
37.6
36
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
9.4
37.5
79
88
L04AB06
ATC
golimumab; parenteral
56.5
37.5
44
8
ZXA05
NOMESCO Finland
Left side
2.4
37.3
366
1740
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
37.2
412
2081
M01AX17
ATC
nimesulide; oral
2.4
37.2
362
1716
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
13.5
37.1
65
50
SPAT1153
SPAT
Removal of sutures
2.2
36.8
459
2453
ZX140
NOMESCO Finland
Intra articular
69.9
36.1
41
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
36.1
170
500
N03AX12
ATC
gabapentin; oral
3.0
36.1
227
829
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
82.1
36.0
40
5
L90
ICPC
Osteoarthrosis of knee
8.0
35.4
82
107
M22.4
ICD-10 Finland
Chondromalacia patellae
30.2
35.3
47
16
WX111
NOMESCO Finland
Local infiltration anesthesia
183.9
34.9
36
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
34.8
246
966
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.7
34.6
162
474
N03AX16
ATC
pregabalin; oral
2.4
34.1
334
1580
M09AX01
ATC
hyaluronic acid; parenteral
10.2
34.0
68
69
1220
FHL
Arthroscopy
8.3
33.8
76
95
M45
ICD-10 Finland
Ankylosing spondylitis
10.5
33.5
66
65
71107
ICD-8 Finland
Acute nonpyogenic arthritis, Loco multiplici
+∞
33.4
32
*
M25.4
ICD-10 Finland
Effusion of joint
22.4
33.2
48
22
ZXA00
NOMESCO Finland
Right side
2.3
33.0
382
1956
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
333.6
33.0
33
*
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
27.2
32.9
45
17
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
32.6
155
459
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
13.4
32.5
57
44
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
32.4
31
*
J01DB01
ATC
cefalexin; oral
2.0
31.7
1253
10249
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
31.5
593
3705
M01AH02
ATC
rofecoxib; oral
3.0
31.4
196
707
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
31.3
557
3405
M17.5
ICD-10 Finland
Other secondary gonarthrosis
318.7
30.9
31
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
30.8
183
638
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
14.5
30.8
52
37
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
30.7
198
732
L89
ICPC
Osteoarthrosis of hip
16.3
30.4
49
31
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
+∞
30.3
29
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.3
30.2
314
1519
M23.8
ICD-10 Finland
Other internal derangements of knee
12.1
29.5
54
46
212
Kela drug reimbursment
Gout
+∞
29.2
28
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
57.8
29.2
34
6
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
16.1
29.1
47
30
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
28.2
27
*
M02AA07
ATC
piroxicam; topical
1.9
28.0
507
3093
M01AB05
ATC
diclofenac; systemic, rectal
1.8
27.5
959
7284
H02AB07
ATC
prednisone; oral
2.5
27.4
231
1000
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
+∞
27.2
26
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
142.3
26.7
28
*
XX9XE
NOMESCO Finland
Other ultrasound examination
29.8
26.3
35
12
M10.0
ICD-10 Finland
Idiopathic gout
11.4
26.2
49
44
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
7.5
25.9
62
86
NF1DA
NOMESCO Finland
X-ray of hips
27.5
25.8
35
13
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
137.2
25.7
27
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.7
25.4
117
337
1222
FHL
Arthroscopy and synovial surgery
50.9
25.3
30
6
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
15.5
25.1
41
27
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
+∞
25.1
24
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
12.1
24.8
45
38
A46
ICD-10 Finland
Erysipelas
2.5
24.8
207
888
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
253.8
24.7
25
*
M03BX02
ATC
tizanidine; oral
1.7
24.7
908
6901
M54.5
ICD-10 Finland
Low back pain
1.9
24.1
459
2821
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
56.9
24.1
28
5
71100
ICD-8 Finland
Acute nonpyogenic arthritis, Humeroscapularis
+∞
24.0
23
*
M01CB03
ATC
auranofin; oral
88.1
23.7
26
*
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
243.4
23.7
24
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
23.7
398
2332
A02BC05
ATC
esomeprazole; systemic
1.8
23.7
572
3803
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
24.0
23.5
33
14
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
23.4
196
841
L28
ICPC
Limited function/disability (L)
2.5
23.3
203
888
M15
ICD-10 Finland
Polyarthrosis
5.7
23.1
67
121
M20.2
ICD-10 Finland
Hallux rigidus
36.9
23.0
29
8
L13
ICPC
Hip symptom/complaint
2.6
22.8
177
727
UJF32
NOMESCO Finland
Coloscopy
2.0
22.7
358
2047
A02BC03
ATC
lansoprazole; oral
1.9
22.5
399
2382
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
11.3
22.0
41
37
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
21.9
21
*
J01FF01
ATC
clindamycin; systemic
1.9
21.8
388
2313
L04AB05
ATC
certolizumab pegol; parenteral
81.2
21.7
24
*
M25.2
ICD-10 Finland
Flail joint
222.8
21.6
22
*
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
8.0
21.6
49
63
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
21.4
392
2360
M01AB01
ATC
indometacin; systemic, rectal
3.2
21.2
114
370
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
50.7
21.1
25
5
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
16.8
21.0
33
20
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.4
21.0
77
181
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
20.9
20
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
20.7
1353
11887
M48.0
ICD-10 Finland
Spinal stenosis
2.8
20.7
140
528
J01DA01
ATC
[U] cefalexin; systemic
1.6
20.6
911
7124
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.0
20.5
84
219
1225
FHL
Arthroscopy and other therapeutic procedure
25.9
20.5
28
11
SPAT1263
SPAT
Sampling
1.7
20.4
610
4275
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
15.3
20.2
33
22
C03CA01
ATC
furosemide; systemic
1.9
20.1
353
2088
ZXE00
NOMESCO Finland
One hour or less
1.7
20.1
562
3860
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.7
19.9
90
256
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
19.8
571
3948
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
19.8
19
*
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
74.4
19.7
22
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
106.3
19.6
21
*
R51.80
ICD-10 Finland
Headache
2.2
19.6
220
1088
A02BC01
ATC
omeprazole; systemic
1.8
19.3
381
2340
H02AB04
ATC
methylprednisolone; systemic
2.2
19.3
207
1003
J01AA02
ATC
doxycycline; systemic
1.7
19.3
1132
9470
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
9.5
19.1
39
42
B01AX06
ATC
[U] rivaroxaban; oral
26.4
19.1
26
10
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
22.8
19.1
27
12
R4110
NOMESCO Finland
Physiotherapy
1.8
18.9
354
2132
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
9.3
18.9
39
43
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
8.1
18.8
42
53
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
18.7
191
901
N06AA09
ATC
amitriptyline; systemic
2.6
18.6
142
575
L17
ICPC
Foot/toe symptom/complaint
1.9
18.5
315
1838
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
18.5
494
3330
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
18.4
156
671
WX110
NOMESCO Finland
Local anesthesy
1.6
18.3
987
8005
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.0
18.1
109
383
N02AA05
ATC
oxycodone; systemic
2.3
17.9
180
844
M19.8
ICD-10 Finland
Other specified arthrosis
6.1
17.9
49
83
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
17.7
17
*
M79.7
ICD-10 Finland
Fibromyalgia
5.5
17.6
52
97
M06
ICD-10 Finland
Other rheumatoid arthritis
96.1
17.6
19
*
NDG30
NOMESCO Finland
Fusion of wrist, total
181.8
17.5
18
*
SPAT1301
SPAT
No procedures
1.7
17.4
435
2863
L08
ICPC
Shoulder symptom/complaint
2.0
17.4
233
1236
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.2
17.3
95
314
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
14.0
17.3
29
21
R4120
NOMESCO Finland
Occupational therapy
3.0
17.1
99
340
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
31.8
17.0
22
7
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
50.5
17.0
20
*
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
50.5
17.0
20
*
J01CA04
ATC
amoxicillin; systemic
1.6
16.9
1192
10249
9271
FHL
Hallux surgery
64.0
16.8
19
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
16.7
444
2971
L04AA17
ATC
[U] adalimumab; parenteral
+∞
16.7
16
*
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
+∞
16.7
16
*
L04AC07
ATC
tocilizumab; parenteral
+∞
16.7
16
*
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
+∞
16.7
16
*
M11.2
ICD-10 Finland
Other chondrocalcinosis
+∞
16.7
16
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.8
16.6
55
117
WZA90
NOMESCO Finland
Other doctors statement
1.8
16.6
308
1844
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
16.4
352
2207
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
16.4
577
4160
R60.0
ICD-10 Finland
Localized oedema
2.4
16.3
146
647
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
5.4
16.1
48
91
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
48.0
16.0
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
15.9
370
2375
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.9
15.9
44
76
WX002
NOMESCO Finland
Sedation and analgesia
1.9
15.8
246
1382
M19.9
ICD-10 Finland
Arthrosis, unspecified
5.8
15.8
44
77
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
+∞
15.6
15
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
15.6
15
*
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
161.4
15.5
16
*
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
161.4
15.5
16
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
15.5
241
1352
R06.0
ICD-10 Finland
Dyspnoea
1.8
15.4
309
1892
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
15.4
233
1296
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.2
15.3
81
261
1221
FHL
Arthroscopy and meniscus surgery
9.8
15.2
30
31
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
15.0
516
3679
Z3226
NOMESCO Finland
Physiotherapist
1.9
14.8
234
1317
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
4.5
14.8
52
118
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.3
14.8
74
229
NHG22
NOMESCO Finland
Fusion of subtalar joint
57.2
14.8
17
*
M79.1
ICD-10 Finland
Myalgia
2.1
14.8
169
838
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
14.7
992
8262
NG2AA
NOMESCO Finland
Patella X-ray examination
13.3
14.7
25
19
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
18.6
14.7
22
12
71102
ICD-8 Finland
Acute nonpyogenic arthritis, Carpi
+∞
14.6
14
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
14.6
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
14.6
95
353
D07AC01
ATC
betamethasone; topical
1.6
14.6
453
3143
J01MA02
ATC
ciprofloxacin; systemic
1.6
14.4
517
3717
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
14.4
175
891
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
14.4
420
2861
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
14.4
703
5434
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
14.3
724
5636
WX204
NOMESCO Finland
Axillary plexus blockaced
4.8
14.3
47
100
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
14.1
601
4494
TQW40
NOMESCO Finland
Remowal of suture of skin
2.7
14.1
96
366
B01AF01
ATC
rivaroxaban; oral
2.5
14.0
111
459
B01AA03
ATC
warfarin; systemic
1.9
13.9
236
1364
M01AB08
ATC
etodolac; oral
2.7
13.9
98
381
M01AB55
ATC
diclofenac, combinations; oral
2.9
13.9
86
309
M02.8
ICD-10 Finland
Other reactive arthropathies
30.3
13.9
18
6
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
7.9
13.9
31
40
R03AC02
ATC
salbutamol; inhalant
1.5
13.8
715
5578
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
13.8
474
3361
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.4
13.7
49
114
SPAT1202
SPAT
Intra-articular injection
5.3
13.7
41
79
M19.2
ICD-10 Finland
Other secondary arthrosis
75.7
13.6
15
*
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
75.7
13.6
15
*
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
+∞
13.6
13
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
13.6
13
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
13.6
13
*
M25.0
ICD-10 Finland
Haemarthrosis
34.3
13.5
17
5
ACC51
NOMESCO Finland
Release of median nerve
2.8
13.5
87
320
L04AA11
ATC
[U] etanercept; parenteral
141.1
13.5
14
*
NGF10
NOMESCO Finland
Total synovectomy of knee, open
141.1
13.5
14
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
13.4
94
364
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
13.4
501
3627
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
13.3
132
616
L16
ICPC
Ankle symptom/complaint
2.3
13.3
127
582
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
13.3
386
2621
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
13.2
308
1966
SPAT1229
SPAT
Assessment of need for aid
2.6
13.0
96
384
M02AA10
ATC
ketoprofen; topical
1.9
12.9
194
1072
P01AB01
ATC
metronidazole; oral, rectal
1.5
12.9
535
3955
N06AX21
ATC
duloxetine; oral
2.2
12.8
138
666
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.4
12.8
46
108
AA1AD
NOMESCO Finland
CT of head and brain
1.7
12.8
284
1786
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
15.5
12.6
20
13
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
7.1
12.6
30
43
ZX120
NOMESCO Finland
Intravenous
2.2
12.5
136
660
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
12.5
12
*
L04AA24
ATC
abatacept; parenteral
+∞
12.5
12
*
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
+∞
12.5
12
*
M16.7
ICD-10 Finland
Other secondary coxarthrosis
130.9
12.4
13
*
M02.1
ICD-10 Finland
Postdysenteric arthropathy
130.9
12.4
13
*
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
130.9
12.4
13
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
130.9
12.4
13
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
12.4
290
1848
M05BA04
ATC
alendronic acid; oral
2.5
12.3
98
408
M25.9
ICD-10 Finland
Joint disorder, unspecified
14.4
12.3
20
14
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
12.2
199
1130
SPAT1312
SPAT
General health counselling
1.6
12.2
430
3052
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.2
12.2
46
113
RT272
NOMESCO Finland
NA
37.8
12.2
15
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
12.1
142
711
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
12.0
218
1283
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
12.0
268
1686
M10
ICD-10 Finland
Gout
3.5
12.0
55
161
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
13.5
11.9
20
15
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
6.8
11.9
29
43
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
47.0
11.9
14
*
ND1AE
NOMESCO Finland
Wrist ultrasound examination
47.0
11.9
14
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
11.8
136
678
L11
ICPC
Wrist symptom/complaint
2.4
11.8
101
438
K02.1
ICD-10 Finland
Caries of dentine
1.5
11.8
781
6343
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
9.0
11.7
24
27
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
11.7
222
1328
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.5
11.7
54
159
71599
ICD-8 Finland
Arthritis, unspecified
30.2
11.6
15
5
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
65.4
11.6
13
*
J01FA06
ATC
roxithromycin; oral
1.5
11.6
530
3985
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
11.5
332
2236
L20
ICPC
Joint symptom/complaint NOS
3.9
11.5
46
120
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
4.8
11.5
37
78
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
11.5
160
861
M02.3
ICD-10 Finland
Reiter disease
+∞
11.5
11
*
1223
FHL
Arthroscopy and articular cartilage surgery
120.8
11.4
12
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.4
259
1633
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
6.4
11.4
29
46
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.4
436
3149
S83.2
ICD-10 Finland
Tear of meniscus, current
2.7
11.3
75
282
NG1AD
NOMESCO Finland
Knee CT examination
8.4
11.3
24
29
L04AC10
ATC
secukinumab; parenteral
35.3
11.3
14
*
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
17.2
11.2
17
10
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
11.2
650
5123
L04AA01
ATC
[U] ciclosporin; systemic
6.8
11.2
27
40
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.3
11.1
55
171
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
11.1
34
68
SPAT1310
SPAT
Counselling related to known health issue
1.5
11.1
416
2990
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.6
11.0
49
140
L01
ICPC
Neck symptom/complaint
1.9
11.0
162
889
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.9
215
1298
R01AD09
ATC
mometasone; nasal
1.5
10.8
606
4731
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
8.3
10.8
23
28
M70.6
ICD-10 Finland
Trochanteric bursitis
2.1
10.8
128
645
M01AC01
ATC
piroxicam; systemic, rectal
1.9
10.8
169
948
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
10.7
107
500
D05AX52
ATC
calcipotriol, combinations; topical
2.6
10.7
76
299
B01AB04
ATC
dalteparin; parenteral
2.9
10.7
64
227
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
60.4
10.6
12
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
10.5
364
2559
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
10.5
122
611
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.7
10.5
70
265
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.5
280
1848
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
10.4
10
*
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
10.4
10
*
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
+∞
10.4
10
*
71101
ICD-8 Finland
Acute nonpyogenic arthritis, Cubiti
+∞
10.4
10
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
10.4
168
951
K07.60
ICD-10 Finland
Snapping jaw
2.6
10.4
76
302
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.8
10.4
65
237
H02AB08
ATC
triamcinolone; systemic
32.7
10.3
13
*
M66.0
ICD-10 Finland
Rupture of popliteal cyst
8.2
10.3
22
27
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.2
10.3
31
61
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.5
10.3
79
324
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
10.3
64
232
L12
ICPC
Hand/finger symptom/complaint
1.9
10.2
165
935
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.6
10.0
28
51
ZXD20
NOMESCO Finland
Day surgery
1.9
10.0
159
898
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.6
9.9
70
273
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
9.9
151
837
M35.7
ICD-10 Finland
Hypermobility syndrome
7.7
9.9
22
29
NDL52
NOMESCO Finland
Tenosynovectomy of hand
16.8
9.9
15
9
M24.2
ICD-10 Finland
Disorder of ligament
12.3
9.8
17
14
X58
ICD-10 Finland
Exposure to other specified factors
1.8
9.8
167
963
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
9.8
135
720
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
9.8
93
424
M19
ICD-10 Finland
Other arthrosis
5.5
9.8
28
52
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
26.2
9.8
13
5
M77.4
ICD-10 Finland
Metatarsalgia
2.7
9.8
63
235
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
9.8
163
935
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
9.7
93
428
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
9.7
413
3037
NH1AD
NOMESCO Finland
Ankle and foot CT
4.6
9.6
32
71
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
9.6
356
2542
L70
ICPC
Infection of musculoskeletal system
15.1
9.5
15
10
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
4.5
9.5
32
72
M01AH03
ATC
valdecoxib; oral
2.4
9.4
77
327
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
5.0
9.4
29
59
M12.3
ICD-10 Finland
Palindromic rheumatism
100.6
9.4
10
*
NGS10
NOMESCO Finland
Incision and debridement of infection of knee joint
100.6
9.4
10
*
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
30.2
9.4
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
9.4
118
611
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
9.4
9
*
9251
FHL
Drainage or flushing of the joint under anesthesia
+∞
9.4
9
*
291
Kela drug reimbursment
Tofacitinib
+∞
9.4
9
*
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
+∞
9.4
9
*
7168A
ICD-9 Finland
Other and unspecified arthropathies, Other specified arthropathy
+∞
9.4
9
*
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.7
9.3
63
242
Z50.1
ICD-10 Finland
Other physical therapy
2.7
9.3
60
225
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
9.3
211
1329
J02AC01
ATC
fluconazole; systemic
1.4
9.2
518
4016
G44.2
ICD-10 Finland
Tension-type headache
1.8
9.2
165
967
Z01.2
ICD-10 Finland
Dental examination
1.4
9.2
527
4103
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.5
9.2
69
281
KMAK
NOMESCO Finland
NA
1.4
9.2
701
5749
73109
ICD-8 Finland
Synovitis, bursitis and tenosynovitis, Unspecified
7.1
9.0
21
30
SPAT1204
SPAT
Arthrocentesis
10.1
9.0
17
17
R05
ICD-10 Finland
Cough
1.6
9.0
227
1471
SPAT1211
SPAT
Application of soft bandage
2.0
8.9
110
563
NDG20
NOMESCO Finland
Fusion of wrist, partial
24.1
8.9
12
5
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.8
8.9
56
205
S80.0
ICD-10 Finland
Contusion of knee
2.3
8.9
77
339
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
8.8
975
8489
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.8
8.8
53
191
-1
NOMESCO Finland
NA
1.4
8.8
440
3330
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
4.4
8.7
30
69
L03
ICPC
Low back symptom/complaint
1.6
8.7
269
1832
XPX04
NOMESCO Finland
Angioscopy
14.1
8.7
14
10
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
8.7
234
1541
288
Kela drug reimbursment
Febuxostat
50.2
8.7
10
*
J04AB02
ATC
rifampicin; systemic
7.7
8.6
19
25
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
8.6
128
706
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
8.6
700
5778
N06AX11
ATC
mirtazapine; oral
1.5
8.6
391
2900
E0000UV
ATC
NA
1.4
8.6
500
3892
R52.2
ICD-10 Finland
Other chronic pain
3.2
8.5
42
132
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
6.4
8.5
21
33
ZXX06
NOMESCO Finland
Extent of procedure, 6 units
90.5
8.4
9
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
90.5
8.4
9
*
349
Kela drug reimbursment
Febuxostat
90.5
8.4
9
*
L04AA29
ATC
tofacitinib; oral
90.5
8.4
9
*
R52.9
ICD-10 Finland
Pain, unspecified
2.0
8.4
102
522
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
8.4
166
1004
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.7
8.4
35
97
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
+∞
8.3
8
*
M12.2
ICD-10 Finland
Villonodular synovitis (pigmented)
+∞
8.3
8
*
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
+∞
8.3
8
*
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
8.6
8.3
17
20
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
8.3
117
631
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.5
8.3
37
108
M70.2
ICD-10 Finland
Olecranon bursitis
3.0
8.3
45
152
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.0
8.3
31
78
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.2
862
7392
C07AB07
ATC
bisoprolol; oral
1.4
8.2
551
4387
A02BA02
ATC
ranitidine; systemic
1.6
8.2
225
1487
H02BX01
ATC
methylprednisolone, combinations; systemic
2.6
8.2
57
224
A04AA01
ATC
ondansetron; systemic, rectal
2.1
8.2
89
433
D07AD01
ATC
clobetasol; topical
1.7
8.2
191
1210
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.2
720
6007
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.1
8.1
43
143
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
8.1
201
1298
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
3.6
8.1
34
95
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
8.0
338
2465
NH3BG
NOMESCO Finland
MRI of foot
10.1
8.0
15
15
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
8.0
490
3837
J01FA10
ATC
azithromycin; systemic
1.4
8.0
770
6507
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
7.9
267
1859
M77.9
ICD-10 Finland
Enthesopathy, unspecified
3.5
7.9
35
102
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.1
7.9
90
450
SPAT1216
SPAT
Assessment of functional ability
1.7
7.8
164
1007
B01AB10
ATC
tinzaparin; parenteral
2.1
7.8
84
409
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.8
173
1081
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
15.1
7.7
12
8
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
7.7
84
412
B01AE07
ATC
dabigatran etexilate; oral
3.1
7.7
40
132
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
7.7
38
121
R02
ICPC
Shortness of breath/dyspnoea
1.8
7.6
127
728
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
7.6
104
554
J01MA12
ATC
levofloxacin; systemic
1.6
7.6
214
1422
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.0
7.6
88
443
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
7.6
300
2158
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
18.4
7.6
11
6
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
18.4
7.6
11
6
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
8.1
7.6
16
20
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
7.6
154
940
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
6.7
7.6
18
27
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
11.9
7.6
13
11
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.8
7.6
137
808
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
10.1
7.5
14
14
N02AJ13
ATC
tramadol and paracetamol; systemic
4.3
7.5
26
61
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
7.5
180
1149
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
7.4
132
771
E000001
ATC
NA
1.5
7.4
249
1726
M15.3
ICD-10 Finland
Secondary multiple arthrosis
80.4
7.4
8
*
9522
FHL
Synovectomy
80.4
7.4
8
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
80.4
7.4
8
*
RT171
NOMESCO Finland
NA
80.4
7.4
8
*
M11.9
ICD-10 Finland
Crystal arthropathy, unspecified
80.4
7.4
8
*
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
80.4
7.4
8
*
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
80.4
7.4
8
*
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
7.3
81
399
L10
ICPC
Elbow symptom/complaint
2.5
7.3
55
226
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
7.3
357
2675
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
7.3
74
351
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
7.3
164
1028
WX290
NOMESCO Finland
Other blockade of nerve
1.4
7.3
566
4600
NDF10
NOMESCO Finland
Synovectomy of wrist
+∞
7.3
7
*
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
+∞
7.3
7
*
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
+∞
7.3
7
*
7143C
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]
+∞
7.3
7
*
A01
ICPC
Pain general/multiple sites
2.1
7.3
83
415
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.8
7.3
43
154
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.9
7.3
28
73
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.3
277
1976
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
7.2
109
606
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
15.8
7.2
11
7
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
15.8
7.2
11
7
C08CA01
ATC
amlodipine; oral
1.4
7.2
399
3062
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
7.2
165
1042
SPAT1254
SPAT
Administration of medicine
1.6
7.2
171
1090
UKC02
NOMESCO Finland
Cystoscopy
1.6
7.2
183
1185
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
7.2
116
659
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
7.2
158
987
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
7.2
189
1240
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
30.1
7.1
9
*
ND2CG
NOMESCO Finland
Extensive MRI of hand
30.1
7.1
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.1
90
468
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
7.1
67
307
R03BA01
ATC
beclometasone; inhalant
1.6
7.1
170
1088
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
7.1
81
403
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.7
7.1
45
167
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.9
7.0
41
145
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
7.0
94
501
M23.3
ICD-10 Finland
Other meniscus derangements
10.1
7.0
13
13
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
10.1
7.0
13
13
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.8
7.0
42
152
N06AX16
ATC
venlafaxine; oral
1.6
7.0
169
1080
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.0
85
434
M43.1
ICD-10 Finland
Spondylolisthesis
2.7
7.0
45
169
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.0
140
853
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.9
333
2486
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
6.9
188
1242
R04.0
ICD-10 Finland
Epistaxis
2.0
6.9
80
402
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
7.6
6.9
15
20
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
13.8
6.9
11
8
QDH05
NOMESCO Finland
Correction of deformity of toe nail
13.8
6.9
11
8
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
4.1
6.9
25
62
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
4.1
6.9
25
62
L04AX01
ATC
azathioprine; systemic
2.4
6.9
56
242
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
6.9
549
4471
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.8
246
1733
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
40.2
6.8
8
*
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
40.2
6.8
8
*
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
40.2
6.8
8
*
M04AA03
ATC
febuxostat; oral
40.2
6.8
8
*
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
16.8
6.7
10
6
M67.3
ICD-10 Finland
Transient synovitis
16.8
6.7
10
6
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
7.2
6.7
15
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.7
155
982
WX200
NOMESCO Finland
Interscalenous plexus blockade
4.1
6.7
24
59
EBA00
NOMESCO Finland
Extraction of tooth
1.4
6.7
395
3060
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
12.3
6.6
11
9
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.8
6.6
26
70
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
6.6
123
735
N05AH04
ATC
quetiapine; oral
1.5
6.6
204
1390
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
6.5
405
3159
WX402
NOMESCO Finland
General anaesthesia
1.5
6.5
204
1393
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
6.9
6.5
15
22
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.6
6.5
27
76
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
6.5
253
1813
M15.8
ICD-10 Finland
Other polyarthrosis
6.2
6.5
16
26
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.2
6.5
16
26
S06.0
ICD-10 Finland
Concussion
1.8
6.4
115
677
M16.5
ICD-10 Finland
Other post-traumatic coxarthrosis
70.1
6.4
7
*
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
70.1
6.4
7
*
NG2EA
NOMESCO Finland
Patella examination using Laurin's projections
70.1
6.4
7
*
M22.1
ICD-10 Finland
Recurrent subluxation of patella
70.1
6.4
7
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
70.1
6.4
7
*
NHG82
NOMESCO Finland
Fusion of other tarsal joint
70.1
6.4
7
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
6.4
104
593
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.4
281
2059
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
14.4
6.4
10
7
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.3
6.4
30
93
J01FA09
ATC
clarithromycin; systemic
1.4
6.3
396
3092
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
6.3
101
572
N62
ICD-10 Finland
Hypertrophy of breast
2.3
6.3
54
238
R4180
NOMESCO Finland
Podiatric therapy
5.5
6.3
17
31
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.3
108
628
A28
ICPC
Limited function/disability NOS
1.7
6.3
138
863
4AC07
NOMESCO Finland
NA
+∞
6.3
6
*
293
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
7192F
ICD-9 Finland
Other and unspecified disorder of joint, Villonodular synovitis[SYNOVITIS VILLONODULARIS, POLVI]
+∞
6.3
6
*
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
6.3
6
*
NHF80
NOMESCO Finland
Operation for debridement of toe joint, open
+∞
6.3
6
*
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
+∞
6.3
6
*
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
+∞
6.3
6
*
7169X
ICD-9 Finland
Other and unspecified arthropathies, Arthropathy, unspecified
+∞
6.3
6
*
NGC99
NOMESCO Finland
Other secondary prosthetic replacement inknee joint, other or unspecified
+∞
6.3
6
*
M15.4
ICD-10 Finland
Erosive (osteo)arthrosis
+∞
6.3
6
*
7118L
ICD-9 Finland
Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, USEAT NIVELET]
+∞
6.3
6
*
NGU00
NOMESCO Finland
Removal of partial prosthesis from knee joint, other or unspecified
+∞
6.3
6
*
71498
ICD-8 Finland
Other specified forms of arthritis, Alia definita
+∞
6.3
6
*
3006
Kela drug reimbursment
Baricitinib
+∞
6.3
6
*
M22.0
ICD-10 Finland
Recurrent dislocation of patella
26.8
6.2
8
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
6.2
66
321
M01AE11
ATC
tiaprofenic acid; oral, rectal
2.6
6.2
42
165
R31
ICD-10 Finland
Unspecified haematuria
1.8
6.2
111
653
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.1
6.1
31
102
Z00.0
ICD-10 Finland
General medical examination
1.5
6.1
213
1490
L60.0
ICD-10 Finland
Ingrowing nail
2.4
6.1
48
205
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.0
6.1
32
108
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
6.1
44
179
Z3231
NOMESCO Finland
Registered nurse
1.4
6.1
330
2513
03992
ICD-8 Finland
Other bacterial diseases, Infectio Yersinia (Pasteurella) enterocolitica
12.6
6.1
10
8
D02AE01
ATC
carbamide; topical
1.9
6.1
80
424
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
6.1
55
249
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
6.1
225
1595
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
6.1
746
6436
ZZH31
NOMESCO Finland
Bone allograft, small pieces
8.6
6.1
12
14
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
6.0
126
774
B01AF02
ATC
apixaban; oral
1.8
6.0
97
552
WZC30
NOMESCO Finland
Teaching
1.6
6.0
156
1018
R52.0
ICD-10 Finland
Acute pain
2.7
6.0
39
147
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.0
372
2899
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000475) Leukocytes [#/volume] in Synovial fluid
233
63
42.51
307.65
2.1
1.2
e6/l
15617.1
13707.3
0.12
179
42
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
288
79
43.44
307.65
1.6
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
206
38
61.31
307.65
1.8
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
152
25
66.48
276.36
1.8
1.1
%
64.0
66.0
0.07
114
13
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
141
21
72.94
260.38
1.8
1.1
%
27.1
26.0
0.04
111
12
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
597
1527
5.41
227.87
1.4
1.1
u/ml
17.8
2.1
6.77
252
647
(3044941) Cell count panel - Synovial fluid
142
52
29.63
211.50
1.6
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
599
1648
5.00
207.32
1.4
1.2
iu/ml
34.4
16.6
3.26
197
462
(3037522) Nuclear Ab [Titer] in Serum
500
1313
4.93
180.76
1.4
1.3
titre
415.3
495.0
0.43
115
238
(3010144) Erythrocytes [#/volume] in Synovial fluid
107
25
45.52
180.54
1.6
1.0
e6/l
19227.9
29875.7
0.16
80
15
(3008898) HLA-B27 [Presence]
211
296
7.97
145.38
1.1
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
721
2909
3.51
137.51
2.7
2.4
umol/l
1997.7
7151.2
4.23
628
2575
(3006315) Basophils [#/volume] in Blood
1148
6262
3.42
130.89
8.7
5.1
e9/l
0.0
0.0
1.08
1061
5362
(3001604) Monocytes [#/volume] in Blood
1140
6239
3.37
128.27
8.6
5.1
e9/l
0.6
0.6
0.38
1052
5341
(3013115) Eosinophils [#/volume] in Blood
1163
6503
3.35
124.90
8.8
5.4
e9/l
0.2
0.2
0.46
1087
5641
(3019198) Lymphocytes [#/volume] in Blood
1154
6462
3.30
122.81
8.7
5.1
e9/l
1.9
1.9
0.01
1077
5637
(3013707) Erythrocyte sedimentation rate by Westergren method
1413
9248
3.73
109.93
7.4
3.1
mm/h
14.0
11.1
10.07
1349
8487
(3013650) Neutrophils [#/volume] in Blood by Automated count
1205
7436
2.99
98.22
11.9
8.9
e9/l
4.1
4.1
0.01
1119
6473
(3024263) Appearance of Synovial fluid
57
19
30.98
86.75
2.5
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
154
270
6.16
85.12
1.6
1.6
iu/ml
0.1
0.2
0.27
32
50
(40760892) CBC W Ordered Manual Differential panel - Blood
614
2842
2.79
84.40
5.9
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
776
4083
2.62
81.95
8.1
5.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
408
1555
3.12
79.57
2.3
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
971
5739
2.55
79.47
9.1
5.3
%
0.7
0.7
1.37
933
5367
(3006504) Eosinophils/100 leukocytes in Blood
986
5918
2.52
77.34
9.1
5.3
%
2.7
2.8
0.77
950
5526
(3019069) Monocytes/100 leukocytes in Blood
988
5954
2.51
76.54
9.4
5.6
%
8.7
8.5
0.75
953
5589
(3015171) Extractable nuclear Ab [Units/volume] in Serum
167
351
5.15
75.69
1.3
1.2
u/ml
1.0
0.6
0.21
21
25
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1387
9942
2.90
72.97
9.6
7.1
u/l
76.3
77.8
0.72
1342
9363
(3002030) Lymphocytes/100 leukocytes in Blood
1001
6165
2.46
72.49
9.2
5.3
%
27.9
28.3
0.50
959
5766
(3018010) Neutrophils/100 leukocytes in Blood
981
6073
2.40
68.98
8.9
5.1
%
57.4
57.0
0.44
945
5705
(3035350) Ketones [Presence] in Urine by Test strip
988
6205
2.36
66.22
4.8
3.1
estimate
0.0
0.0
0.00
236
1122
(3029937) Albumin [Presence] in Urine by Test strip
634
3289
2.45
65.81
5.5
3.3
estimate
0.0
0.0
0.24
237
1108
(3021601) Nitrite [Presence] in Urine by Test strip
987
6207
2.35
65.79
6.0
4.4
estimate
0.0
0.0
0.50
249
1140
(3009261) Glucose [Presence] in Urine by Test strip
993
6288
2.34
64.74
4.9
3.2
estimate
0.0
0.0
1.32
239
1102
(3037467) Urinalysis macro (dipstick) panel - Urine
1259
8847
2.51
64.48
5.5
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
755
4405
2.26
57.97
3.9
2.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
44
22
20.49
57.48
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
125
275
4.82
53.40
1.6
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
258
950
3.01
51.90
4.5
4.1
%
0.8
0.9
0.22
65
268
(3021589) Normoblasts [#/volume] in Blood
899
5807
2.13
51.44
13.4
8.3
e9/l
0.0
0.0
0.00
795
4679
(3025159) Blasts/100 leukocytes in Blood
239
848
3.11
51.26
4.6
4.2
%
0.2
0.5
0.40
52
213
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
130
306
4.51
51.07
2.1
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
248
903
3.03
50.83
4.5
4.2
%
0.2
0.2
0.44
61
252
(3011397) Hemoglobin [Presence] in Urine by Test strip
519
2772
2.24
47.58
5.0
3.1
—
—
—
0
0
(3015736) pH of Urine
769
4794
2.08
47.12
4.6
3.0
—
5.9
—
0
7
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
777
4871
2.07
46.80
5.2
3.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
235
872
2.96
46.38
4.1
4.0
%
0.3
0.7
2.06
47
197
(40761535) Cells panel - Urine sediment
241
914
2.90
45.69
4.4
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
568
3216
2.13
44.41
8.1
6.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
96
205
4.90
42.41
3.2
3.8
%
55.5
56.8
0.42
96
205
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
905
6135
1.98
42.39
7.5
6.7
mmol/l
1.2
1.2
0.55
759
5167
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
836
5526
1.98
42.01
6.5
6.0
mmol/l
1.2
1.2
0.40
781
4993
(3030905) Polymorphonuclear cells [#/volume] in Blood
93
196
4.95
41.72
3.1
3.4
e9/l
3.9
3.9
0.07
93
196
(3018095) Leukocytes [#/volume] in Urine
699
4357
2.01
41.44
4.1
3.3
e6/l
103.1
128.1
0.31
518
3020
(3023368) Bacteria identified in Blood by Culture
558
3217
2.08
40.99
4.9
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
595
3525
2.04
40.48
2.2
2.1
u/l
208.5
279.9
0.50
557
3298
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
76
142
5.55
39.02
2.1
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
209
799
2.83
38.78
2.4
2.3
au/ml
29.3
19.7
—
10
53
(3000850) Epithelial cells [#/volume] in Urine
458
2510
2.12
38.08
2.9
2.4
e6/l
4.4
6.7
3.46
416
2172
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
108
282
4.02
36.90
1.3
1.5
g/l
0.2
0.2
0.52
101
268
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1594
13656
2.87
36.71
21.6
11.9
mg/l
21.2
25.1
5.56
1405
10341
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
110
293
3.94
36.56
1.3
1.5
g/l
1.2
1.2
0.08
103
276
(3024561) Albumin [Mass/volume] in Serum or Plasma
800
5396
1.89
36.09
5.0
4.9
g/l
35.4
35.7
0.56
741
5023
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
770
5140
1.89
35.79
2.5
2.1
nmol/l
77.1
76.2
0.37
713
4638
(3002582) Erythrocytes [#/volume] in Urine
599
3730
1.92
34.08
3.5
2.9
e6/l
90.7
66.0
0.20
478
2815
(36304419) Bacteria [Presence] in Urine
546
3297
1.95
34.05
3.2
2.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
465
2670
2.01
33.44
5.8
3.4
kg/l
1.0
1.0
0.14
46
383
(3031040) Bacteria [#/volume] in Urine by Automated count
1113
8458
1.87
33.25
5.2
3.9
e6/l
1754.8
2216.6
0.11
16
127
(3030467) Casts [#/volume] in Urine by Automated count
550
3360
1.93
32.93
3.2
2.8
e6/l
0.3
0.5
1.64
433
2493
(3015377) Calcium [Moles/volume] in Serum or Plasma
656
4275
1.85
31.93
3.2
3.6
mmol/l
2.4
2.4
0.61
590
3787
(3018418) pH of Serum or Plasma
567
3570
1.87
30.49
4.5
3.9
ph
7.4
7.4
1.44
133
707
(3032080) INR in Blood by Coagulation assay
708
4827
1.78
28.96
9.9
8.2
inr
1.2
1.2
0.03
232
1443
(3013826) Glucose [Moles/volume] in Serum or Plasma
992
7513
1.74
27.51
5.3
4.7
mmol/l
6.8
6.7
0.60
940
6956
(3007853) Bacteria identified in Skin by Aerobe culture
270
1367
2.15
26.68
2.4
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
905
6717
1.72
26.68
5.8
6.6
umol/l
10.7
11.7
1.82
859
6373
(3004588) Protein electrophoresis panel - Serum or Plasma
166
692
2.55
25.67
1.5
2.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
675
4660
1.73
25.59
4.3
3.2
ng/l
34.7
63.0
1.25
483
2966
(3009445) Proteinase 3 Ab [Units/volume] in Serum
124
446
2.92
25.54
2.1
1.5
u/ml
14.1
8.0
—
7
8
(3017143) Hepatitis C virus Ab [Presence] in Serum
278
1459
2.08
24.90
1.5
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
791
5744
1.69
24.59
4.5
3.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
195
893
2.33
24.51
1.7
3.1
g/l
67.1
66.4
0.63
187
816
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
67
167
4.13
24.37
1.6
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
324
1826
1.95
23.66
3.0
2.3
umol/l
12.4
14.0
3.63
305
1679
(3001122) Ferritin [Mass/volume] in Serum or Plasma
784
5730
1.67
23.42
3.1
2.6
ug/l
137.4
123.0
0.62
733
5344
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
487
3150
1.76
22.74
3.5
3.0
ng/l
1761.1
1363.5
0.60
419
2670
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1635
14800
2.58
22.58
21.9
13.8
umol/l
79.5
75.7
2.73
1635
14794
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
476
3069
1.76
22.43
2.5
2.0
mg/l
3.0
2.9
1.19
415
2582
(3004789) Transferrin [Mass/volume] in Serum or Plasma
294
1669
1.92
20.81
3.0
2.3
g/l
2.3
2.3
1.08
277
1543
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
571
3942
1.67
20.60
2.8
2.6
u/l
55.6
58.4
0.97
527
3646
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
337
2007
1.84
20.52
2.6
2.6
e6/l
0.9
1.1
0.88
211
1098
(3005719) IgG [Mass/volume] in Serum or Plasma
183
880
2.21
20.36
2.3
2.7
g/l
10.9
10.4
0.91
172
794
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
277
1557
1.93
20.16
3.0
2.4
%
22.5
23.9
0.88
242
1330
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1476
12985
1.87
19.94
16.5
11.2
ml/min/173m2
83.7
83.5
0.11
1291
10529
(3003458) Phosphate [Moles/volume] in Serum or Plasma
282
1600
1.91
19.93
6.7
5.8
mmol/l
1.1
1.0
1.07
264
1482
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
66
190
3.57
19.62
1.1
1.2
u/ml
1.4
1.6
—
5
20
(40761536) Microorganisms panel - Urine sediment
212
1107
2.04
19.00
4.5
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
332
2018
1.80
18.75
1.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1433
12573
1.77
18.49
4.9
4.5
mu/l
3.1
2.1
0.37
1333
11524
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
22
24
9.27
18.22
1.5
2.6
mg/l
9.3
7.5
0.51
16
19
(3019550) Sodium [Moles/volume] in Serum or Plasma
1560
14075
1.99
18.08
19.7
13.9
mmol/l
139.5
139.7
2.92
1533
13666
(3022217) INR in Platelet poor plasma by Coagulation assay
255
1447
1.89
17.91
26.4
21.2
inr
1.3
1.3
0.03
33
201
(3023103) Potassium [Moles/volume] in Serum or Plasma
1564
14135
2.00
17.87
19.8
14.0
mmol/l
4.0
4.0
2.32
1537
13693
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
121
515
2.45
17.83
1.7
2.0
u/l
39.0
38.2
0.17
113
460
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
179
899
2.10
17.78
2.4
2.5
ml/min/173m2
67.0
69.4
0.34
85
343
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
419
2757
1.68
17.73
2.1
1.8
mg/l
1.0
1.2
0.53
317
2054
(3027945) Reticulocytes/100 erythrocytes in Blood
229
1259
1.94
17.68
2.5
2.6
%
1.7
1.7
0.17
202
1117
(3019309) Folate [Moles/volume] in Red Blood Cells
340
2114
1.75
17.67
1.8
1.7
nmol/l
1310.5
1140.0
2.66
256
1615
(3021879) Hepatitis B virus core Ab [Presence] in Serum
179
902
2.10
17.62
1.3
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1621
14868
2.22
17.39
15.7
8.8
u/l
26.7
26.4
0.32
1586
14333
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
175
882
2.09
17.21
4.3
3.8
ng/l
91.0
86.0
0.27
150
765
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
357
2266
1.72
17.20
2.3
3.2
mmol/l
2.5
2.4
0.13
315
2007
(3045414) Leukocytes [Presence] in Urine
114
483
2.45
16.97
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
520
3652
1.60
16.84
3.2
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
376
2437
1.69
16.72
3.2
2.5
mosm/kgh2o
534.6
550.8
0.76
336
2059
(3021960) Folate [Moles/volume] in Serum or Plasma
409
2724
1.65
16.35
1.6
1.5
nmol/l
21.4
20.3
0.43
355
2348
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
312
1932
1.75
16.34
1.8
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
44
109
4.11
16.18
1.1
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
26
41
6.42
15.85
1.2
1.2
iu/ml
220.0
205.8
0.08
26
41
(3041096) Erythrocytes [Presence] in Urine by Automated
500
3525
1.59
15.75
4.1
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
252
1484
1.82
15.62
9.8
6.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1591
14589
1.99
15.54
18.5
11.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
141
686
2.15
15.17
1.5
1.9
g/l
1.4
1.5
0.04
132
622
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
68
239
2.92
14.64
1.2
1.2
u/ml
2.0
2.4
—
9
30
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
655
4967
1.51
14.58
2.0
1.9
pmol/l
95.8
94.7
0.24
338
2617
(3002385) Erythrocyte distribution width [Ratio]
1328
11649
1.58
14.55
22.7
14.9
%
13.8
13.6
5.12
1316
11348
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
68
240
2.91
14.53
1.2
1.2
u/ml
3.3
7.2
0.44
14
41
(46235355) HIV 1 and 2 tests - Meaningful Use set
374
2509
1.62
14.30
1.7
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
540
3944
1.53
14.28
2.4
2.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
317
2040
1.68
14.27
3.4
3.7
mmol/l
0.8
0.8
0.89
299
1912
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
211
1215
1.84
14.01
3.7
3.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
30
63
4.83
13.56
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
30
63
4.83
13.56
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
30
63
4.83
13.56
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1210
10472
1.50
13.42
4.2
3.8
pmol/l
14.8
14.7
0.96
1115
9540
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
224
1338
1.77
13.14
3.5
4.6
u/l
226.6
247.1
1.93
213
1272
(3013512) EKG study
482
3491
1.53
13.04
4.4
3.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
367
2503
1.59
12.97
1.4
1.5
g/l
2.5
2.3
1.15
245
1559
(3044889) 12 lead EKG panel
1094
9316
1.46
12.87
4.2
3.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
29
63
4.66
12.61
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
29
63
4.66
12.61
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
29
63
4.66
12.61
1.2
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
197
1147
1.81
12.58
2.1
2.2
nmol/l
342.1
386.3
2.76
185
1049
(3048689) Calprotectin [Mass/mass] in Stool
243
1509
1.71
12.39
2.4
2.3
ug/g
100.7
129.1
1.24
187
1210
(40768797) Stomach Pathology biopsy report
258
1649
1.66
11.78
1.3
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
183
1066
1.80
11.65
6.2
7.3
mmol/l
1.5
1.4
0.27
178
1027
(3023520) Reticulocytes [#/volume] in Blood
161
905
1.86
11.50
2.0
2.8
e9/l
68.8
69.0
0.03
118
687
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
231
1445
1.69
11.43
1.7
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
170
994
1.79
10.68
2.8
2.4
ug/l
5.2
7.4
1.65
157
873
(3017732) Neutrophils [#/volume] in Blood
147
834
1.83
10.19
2.9
3.2
e9/l
3.9
4.0
0.38
109
668
(3020891) Body temperature
96
471
2.10
10.15
4.8
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
214
1353
1.66
10.13
1.7
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
172
1029
1.74
9.98
5.5
3.6
mmol/l
1.2
1.2
0.04
150
883
(3000494) Fungus identified in Specimen by Culture
221
1423
1.63
9.73
1.6
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1658
15750
1.99
9.73
30.3
17.5
e9/l
259.1
251.8
4.48
1637
15272
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
211
1344
1.65
9.70
1.7
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
1658
15763
1.98
9.50
30.2
17.4
fl
91.3
90.7
6.27
1650
15500
(3003396) Base excess in Arterial blood by calculation
214
1375
1.63
9.50
7.4
8.6
mmol/l
0.7
1.0
0.61
182
1064
(3035941) MCH [Entitic mass]
1658
15764
1.97
9.48
30.1
17.4
pg
30.3
30.2
0.59
1649
15500
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
93
463
2.07
9.47
1.8
2.1
ug/l
2.2
1.3
0.43
83
414
(3026361) Erythrocytes [#/volume] in Blood
1658
15765
1.97
9.46
30.3
17.5
e12/l
4.4
4.5
14.40
1634
15242
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
244
1620
1.59
9.46
1.9
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1658
15769
1.97
9.40
30.3
17.5
e9/l
6.9
6.7
2.35
1632
15238
(3000963) Hemoglobin [Mass/volume] in Blood
1658
15771
1.97
9.36
30.4
17.5
g/l
133.4
136.2
12.31
1648
15505
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
397
2938
1.45
9.20
2.3
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
168
1022
1.71
9.18
7.8
8.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
73
335
2.23
9.15
1.8
3.9
mg/l
33.3
61.8
0.90
55
282
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1367
12458
1.44
9.00
6.1
5.1
mmol/mol
39.9
39.5
0.64
1279
11514
(3018677) aPTT in Platelet poor plasma by Coagulation assay
279
1931
1.53
8.98
3.2
2.2
s
30.6
29.7
1.52
270
1873
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
80
384
2.14
8.98
2.4
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
49
189
2.64
8.96
1.4
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
39
133
2.98
8.95
9.0
7.5
mg/l
10.4
12.1
1.43
33
122
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
392
2909
1.45
8.92
1.3
1.3
u/ml
0.9
1.8
1.33
108
762
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
33
103
3.25
8.78
1.1
1.1
u/l
47.3
60.8
1.22
24
69
(3020779) Urea [Moles/volume] in Serum or Plasma
173
1076
1.67
8.71
10.2
7.6
mmol/l
11.2
9.2
2.70
163
1026
(3005322) IgE [Units/volume] in Serum or Plasma
136
793
1.78
8.63
1.3
1.3
u/ml
292.5
228.0
0.18
123
730
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
552
4377
1.38
8.54
3.1
3.3
u/l
32.6
34.2
0.24
525
4173
(3034860) Kappa light chains.free [Mass/volume] in Serum
71
333
2.18
8.46
1.8
3.9
mg/l
56.8
56.9
0.00
53
279
(3019060) Gas panel - Arterial blood
135
795
1.76
8.28
4.8
6.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
435
3332
1.41
8.22
4.3
3.8
%
90.8
91.0
0.05
424
3233
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
140
836
1.73
8.18
1.7
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
42
4.56
8.12
1.2
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
43
164
2.66
8.07
1.3
1.3
—
—
—
0
0
(3010421) pH of Blood
70
333
2.15
8.06
3.8
3.6
ph
7.4
7.4
0.40
56
268
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
68
324
2.14
7.81
1.8
3.9
ratio
1.1
1.8
—
9
29
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1042
9191
1.33
7.64
3.2
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
208
2.39
7.40
1.3
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
272
1947
1.47
7.37
3.1
2.6
e6/l
2.2
2.5
0.32
149
1040
(3004809) Band form neutrophils/100 leukocytes in Blood
43
172
2.54
7.36
3.3
3.5
%
0.7
1.4
2.00
35
140
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
354
2663
1.41
7.33
1.7
1.6
pmol/l
449.1
32646169.4
2.65
288
2230
(40760888) Immunoglobulin light chains.free panel - Serum
54
241
2.28
7.29
1.9
4.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
205
2.38
7.16
4.6
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
328
2450
1.42
7.05
1.6
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
414
1.95
7.05
1.6
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
414
1.95
7.05
1.6
2.3
g/l
7.6
7.2
1.26
63
303
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
304
2.11
7.04
1.3
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
52
232
2.28
7.03
2.2
2.4
%
16.4
16.3
0.07
27
106
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
170
2.51
7.03
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
179
1190
1.56
6.87
2.3
2.3
g/l
0.2
0.2
0.10
167
1122
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
55
254
2.20
6.86
1.3
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
390
1.96
6.85
1.6
2.4
g/l
3.1
3.0
0.19
61
296
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
414
1.93
6.72
1.6
2.3
g/l
4.3
3.7
1.91
60
288
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
34
127
2.71
6.68
1.6
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
88
487
1.85
6.67
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
65
327
2.03
6.52
1.2
1.2
titre
81.7
92.3
—
6
26
(21494890) Protein electrophoresis panel - 24 hour Urine
31
113
2.77
6.39
1.5
2.6
—
—
—
0
0
(4010399)
131
828
1.63
6.22
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
51
239
2.17
6.17
2.2
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
59
293
2.05
6.15
1.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
35
139
2.55
6.13
1.6
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
644
5429
1.29
6.09
2.1
2.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
56
274
2.08
6.07
4.1
3.7
kpa
8.3
8.7
0.84
56
266
(3012501) Base excess in Blood by calculation
56
275
2.07
6.02
4.1
3.7
mmol/l
3.1
2.5
0.59
40
190
(3013290) Carbon dioxide [Partial pressure] in Blood
56
275
2.07
6.02
4.1
3.7
kpa
5.0
5.1
0.17
56
268
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
43
190
2.29
5.99
1.3
1.2
u/ml
3.6
4.5
0.14
22
61
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
169
2.34
5.69
1.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
114
713
1.64
5.67
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
51
249
2.08
5.59
4.2
3.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
48
229
2.13
5.58
1.2
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
377
1.86
5.50
1.5
2.4
g/l
11.0
10.3
0.58
64
315
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
166
2.32
5.46
1.3
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
465
3803
1.30
5.41
4.5
3.8
mg/mmol
16.9
8.6
1.47
290
2399
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1418
13316
1.34
5.40
4.6
4.1
mmol/l
6.0
5.9
1.84
1313
12186
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1029
9283
1.26
5.32
3.6
2.9
u/l
51.6
46.6
1.04
958
8718
(3022145) Colonoscopy Study observation
198
1418
1.45
5.32
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
503
1.73
5.22
1.6
1.9
g/l
1.8
1.5
1.63
66
431
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.21
1.4
0.0
mg/l
25.0
—
—
5
0
(3009508) Creatinine [Moles/volume] in Urine
475
3918
1.29
5.14
3.5
3.1
mmol/l
7.6
7.7
0.30
389
3308
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
92
2.74
5.11
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
185
2.19
5.05
1.3
1.2
u/ml
3.6
3.9
0.11
20
90
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
122
2.48
5.05
4.4
4.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
212
2.10
5.02
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
437
3603
1.28
4.69
3.7
3.1
mg/l
524.3
437.5
0.12
284
2240
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
375
1.79
4.69
5.1
3.7
u/ml
0.3
0.3
0.42
45
205
(4268621)
30
127
2.39
4.66
2.3
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1451
13754
1.32
4.56
4.5
4.0
mmol/l
4.7
4.7
1.50
1355
12799
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1472
13987
1.33
4.51
5.0
4.4
mmol/l
2.8
2.8
1.15
1366
12940
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
99
2.55
4.47
1.3
1.3
—
—
—
0
0
(4306422)
40
195
2.08
4.46
1.2
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
115
770
1.53
4.34
7.5
7.6
mmol/l
24.7
24.8
0.08
115
762
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1395
13181
1.29
4.30
4.0
3.6
mmol/l
1.3
1.3
1.20
1294
12123
(21494755) Public health laboratory ask at order entry panel
111
1623
0.66
4.27
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
38
187
2.05
4.15
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
91
2.55
4.14
1.5
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
116
2.35
4.09
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
116
2.35
4.09
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
116
2.35
4.09
1.5
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
39
195
2.02
4.09
1.2
1.1
%
117.0
115.9
0.08
39
174
(3028271) Lactate [Moles/volume] in Capillary blood
37
182
2.06
4.06
1.8
1.6
mmol/l
1.4
1.7
2.00
37
173
(3049717) Cytology report of Urine Cyto stain
71
431
1.67
4.04
2.5
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
231
1.93
4.03
1.9
2.5
g/l
129.9
129.1
0.06
34
162
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
72
439
1.67
4.03
1.8
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
239
1.91
3.99
1.2
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
105
703
1.53
3.98
3.5
3.8
mmol/l
1.7
1.8
0.12
75
523
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1437
13664
1.29
3.98
4.5
4.0
mmol/l
1.5
1.5
0.19
1340
12637
(3042631) Mycobacterium sp identified in Specimen
33
157
2.12
3.95
2.1
2.3
—
—
—
0
0
(3019225) pH of Specimen
162
1183
1.41
3.94
4.8
4.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
131
2.23
3.93
1.2
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
48
3.14
3.93
1.1
1.4
—
—
—
0
0
(3036489) Thrombin time
80
505
1.61
3.92
2.7
2.1
s
20.8
21.5
0.95
73
446
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
366
1.72
3.91
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
18
65
2.79
3.86
1.4
3.1
u/ml
815.1
1100.4
0.34
18
65
(3025941) Bacteria identified in Stool by Culture
103
692
1.52
3.85
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
103
692
1.52
3.85
1.8
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
72
445
1.64
3.84
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
39
200
1.97
3.84
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
34
166
2.07
3.82
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
108
735
1.50
3.81
3.6
3.9
kpa
5.1
5.2
0.47
97
681
(44813793)
21
83
2.55
3.80
1.0
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
158
1157
1.40
3.79
4.4
3.7
mmol/l
1.9
1.8
0.08
134
914
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
5
12.03
3.76
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
39
3.35
3.76
1.2
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
107
730
1.50
3.73
3.6
3.8
ph
7.4
7.4
1.11
18
76
(3021901) Oxygen saturation in Capillary blood
39
203
1.94
3.69
2.3
3.1
—
—
—
0
0
(3012544) pH of Venous blood
162
1200
1.39
3.64
4.4
3.7
—
7.4
—
0
5
(3022621) pH of Urine by Test strip
112
776
1.47
3.63
2.6
2.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
35
3.45
3.62
1.5
2.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
43
234
1.86
3.57
1.2
1.2
u/ml
219.0
248.2
0.39
21
142
(3000093) Morphology [Interpretation] in Blood Narrative
22
92
2.41
3.56
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
39
206
1.91
3.55
1.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
16
57
2.82
3.52
2.1
2.8
ml
2060.1
1904.4
0.22
16
52
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
45
250
1.82
3.51
1.2
1.2
—
—
—
0
0
(44790048)
30
145
2.09
3.48
1.4
1.5
—
—
—
0
0
(44790047)
30
145
2.09
3.48
1.4
1.5
—
—
—
0
0
(44790049)
30
145
2.09
3.48
1.4
1.5
—
—
—
0
0
(44806118)
30
145
2.09
3.48
1.4
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
434
1.61
3.46
2.8
3.7
g/l
0.5
0.3
0.59
26
192
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
135
978
1.41
3.46
1.2
1.2
iu/ml
140.6
152.6
0.13
50
365
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
139
2.10
3.44
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
57
342
1.69
3.43
2.9
3.4
—
—
—
0
0
(4062490)
25
113
2.23
3.42
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
97
662
1.49
3.40
1.3
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
56
336
1.69
3.37
3.8
3.2
mg/l
1.6
1.4
0.75
50
310
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
81
534
1.54
3.34
4.3
3.6
%
55.5
50.3
1.16
81
525
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
141
2.07
3.33
1.4
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
37
197
1.90
3.31
1.3
1.2
u/ml
49.1
48.1
—
9
21
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
29
142
2.06
3.27
1.4
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
43
3.04
3.25
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
43
3.04
3.25
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
43
3.04
3.25
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
43
3.04
3.25
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
56
340
1.67
3.24
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1371
13051
1.23
3.22
18.9
13.1
%
39.5
40.0
1.11
939
9814
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
72
2.52
3.21
1.2
1.2
ratio
1.1
1.1
—
7
30
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
49
2.87
3.19
1.3
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
468
4041
1.22
3.19
4.3
4.6
ug/l
2.2
2.8
1.26
418
3615
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
61
2.64
3.13
1.4
1.4
u/l
5.8
7.8
—
9
27
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
55
336
1.66
3.12
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
55
336
1.66
3.12
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
92
2.30
3.10
1.2
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
140
2.02
3.01
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
140
2.02
3.01
1.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
204
1.83
3.00
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
100
2.22
3.00
4.0
3.5
%
54.9
57.3
0.17
17
64
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
40
3.01
2.97
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
28
141
2.00
2.96
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
56
351
1.62
2.90
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
86
597
1.46
2.82
3.3
3.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
123
2.05
2.82
1.3
1.9
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
18
4.46
2.79
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
72
483
1.51
2.79
1.9
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
92
652
1.43
2.72
8.6
12.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
54
2.61
2.70
3.4
3.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
37
2.99
2.69
1.2
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
19
4.23
2.68
1.3
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
24
3.76
2.67
1.1
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
129
972
1.35
2.67
2.7
2.9
ng/l
243.2
194.0
0.42
117
877
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
55
352
1.58
2.64
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
38
2.91
2.58
1.7
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
44
2.74
2.55
2.1
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
81
2.23
2.54
2.9
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
129
1.95
2.50
1.3
1.3
e6/l
78384.2
101168.8
0.16
20
78
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
69
2.33
2.48
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
63
2.39
2.46
1.1
2.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
196
1.75
2.44
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
60
400
1.52
2.43
1.8
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
27
3.35
2.39
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
45
282
1.61
2.38
2.7
3.7
mmol/l
24.6
25.2
0.38
39
254
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
40
2.76
2.37
1.3
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
8
6.26
2.37
1.6
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
23
119
1.95
2.31
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
35
2.87
2.30
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
167
1335
1.28
2.29
1.6
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
82
590
1.41
2.28
3.0
2.4
%
1.4
1.2
1.00
82
585
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
67
468
1.45
2.19
4.0
3.9
mmol/l
24.8
24.9
0.06
57
434
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
40
250
1.61
2.16
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
76
546
1.41
2.14
3.9
3.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
33
197
1.69
2.13
1.2
1.4
u/l
26.3
26.4
0.01
26
172
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
82
598
1.39
2.12
3.9
3.9
mmol/l
24.1
24.0
0.10
71
550
(3004451) EKG impression Narrative
13
55
2.37
2.12
1.9
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
72
514
1.42
2.11
1.1
1.1
—
0.9
—
0
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
43
2.57
2.09
1.1
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
62
2.27
2.08
1.2
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
183
1500
1.25
2.05
2.3
2.9
umol/l
5.4
8.0
4.60
158
1310
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
96
1.99
2.05
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
390
3439
1.17
2.03
1.7
1.6
mmol/l
1.4
1.4
0.35
315
2884
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
104
1.93
2.00
2.9
2.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
23
126
1.84
1.98
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
11
4.56
1.94
1.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
16
3.76
1.93
1.8
3.5
u/field
0.5
0.7
—
6
16
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
71
2.12
1.92
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
115
1455
0.78
1.90
1.8
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
74
542
1.38
1.90
2.1
2.2
u/l
5457.2
4181.6
0.18
25
220
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
79
586
1.36
1.88
2.4
2.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
22
3.19
1.88
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
264
0.49
1.86
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
79
2.03
1.85
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
79
2.03
1.85
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
164
1345
1.24
1.85
3.5
4.5
ug/l
14.8
26.3
0.40
142
1093
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
17
3.54
1.84
1.5
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
17
3.54
1.84
1.3
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
249
0.48
1.83
1.3
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
12
4.18
1.82
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
200
1.61
1.78
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
256
1.54
1.77
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
30
185
1.63
1.76
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
147
1.71
1.74
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
13
3.85
1.71
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
82
1.96
1.69
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
402
1.41
1.65
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
75
982
0.75
1.63
1.5
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
20
113
1.78
1.60
1.3
1.4
promille
1.1
1.3
0.15
13
89
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
70
2.01
1.59
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
26
2.70
1.58
1.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
38
256
1.50
1.56
1.4
1.4
—
17.3
—
0
7
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
200
1.56
1.54
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
78
1.93
1.54
1.5
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
15
3.34
1.52
1.2
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
200
1711
1.19
1.51
1.3
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
27
2.60
1.51
1.1
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
25
154
1.63
1.50
2.2
2.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
211
1.53
1.46
1.0
1.0
u/ml
2.9
2.0
0.39
14
106
(3044927) Protein electrophoresis panel - Urine
18
102
1.77
1.45
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
80
1.88
1.44
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
52
2.12
1.44
2.2
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
254
1.47
1.41
1.6
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
23
2.61
1.37
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
269
2380
1.15
1.36
3.5
3.5
ng/l
226.0
939.1
0.93
191
1765
(3044290) Cell count panel - Cerebral spinal fluid
39
273
1.44
1.35
1.2
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
172
1468
1.19
1.35
1.8
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
20
120
1.67
1.34
1.6
2.4
e9/l
1.0
1.2
0.44
15
77
(3006462) Nitrate [Presence] in Urine
10
47
2.13
1.33
3.0
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
42
2.15
1.33
2.2
2.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
136
1.63
1.32
1.2
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
91
1.77
1.29
1.8
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
104
851
1.24
1.27
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
124
1034
1.21
1.26
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
358
3249
1.13
1.24
4.1
4.0
%
23.4
22.1
0.75
163
1536
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
108
1.67
1.22
1.0
1.2
u/ml
0.1
0.3
—
10
51
(4211845)
10
49
2.05
1.22
3.0
3.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
19
2.64
1.21
3.8
7.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
37
2.17
1.21
1.1
1.1
—
—
—
0
0
(4024509)
16
93
1.73
1.21
1.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
67
850
0.78
1.21
1.8
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
46
340
1.36
1.20
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
18
109
1.66
1.19
1.6
2.1
u/field
1.1
1.8
0.55
13
45
(3039443) Prostate specific Ag panel - Serum or Plasma
16
262
0.61
1.19
1.8
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
26
2.31
1.18
2.3
3.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
26
2.31
1.18
1.2
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
26
2.31
1.18
1.3
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
181
1.50
1.18
1.2
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
8
38
2.11
1.18
1.1
2.0
pmol/l
14.3
13.2
—
8
33
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
79
1.78
1.17
1.4
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
49
368
1.34
1.17
1.0
1.1
u/ml
0.9
4.5
—
6
59
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
65
1.85
1.13
1.2
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
30
2.34
1.12
1.4
1.7
ug/l
7.7
9.0
—
7
30
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
10
183
0.54
1.12
1.0
1.9
—
1024.0
—
0
10
(4034850)
57
442
1.30
1.10
7.1
8.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
49
372
1.33
1.10
1.2
1.5
u/l
10.7
9.7
0.17
36
302
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
201
1.45
1.10
1.3
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
168
1461
1.17
1.09
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
81
1.73
1.09
1.4
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
21
136
1.55
1.08
1.2
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
28
194
1.45
1.07
2.8
2.7
u/ml
1661.1
1372.5
0.05
28
184
(3003338) MCHC [Mass/volume]
1254
12189
1.10
1.06
25.7
15.3
g/l
331.4
332.9
6.61
1254
12096
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
194
1710
1.15
1.06
2.1
1.8
%
1.4
1.4
0.09
165
1542
(40768446) Kidney Pathology biopsy report
10
52
1.93
1.06
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
113
1.60
1.05
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
150
0.53
1.03
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
114
1.58
1.02
1.3
1.3
—
—
—
0
0
(4146454)
19
122
1.56
1.02
3.8
2.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
107
1.59
0.99
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
115
1.57
0.99
1.3
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
98
822
1.20
0.99
2.8
3.4
pmol/l
4.5
4.5
0.02
84
743
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
149
1.48
0.95
1.3
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
64
516
1.25
0.94
5.2
7.4
%
1.7
1.6
0.34
64
479
(3000012) Reticulocyte production index
11
62
1.78
0.94
1.2
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(4133840)
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
54
429
1.27
0.91
1.5
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
29
2.07
0.89
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
139
1215
1.16
0.88
2.1
2.4
u/l
30.2
77.8
0.66
116
1051
(4198724)
10
56
1.79
0.88
1.3
1.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
63
513
1.24
0.87
5.2
7.5
%
0.9
0.9
0.15
63
477
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
56
450
1.25
0.86
1.3
1.3
miu/ml
225.8
217.4
0.06
25
220
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
64
1.72
0.86
1.2
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
44
1.82
0.86
2.9
3.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
1.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
1.3
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
80
1.63
0.84
1.1
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
45
1.78
0.84
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
32
240
1.34
0.82
1.3
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
48
383
1.26
0.80
1.6
1.7
nmol/l
44.8
39.7
0.63
48
370
(3045142) Bone marrow Pathology biopsy report
21
148
1.42
0.78
1.2
1.4
—
—
—
0
0
(3000492) Spirometry study
146
1296
1.14
0.77
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
115
1.48
0.77
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
166
1.39
0.75
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
11
67
1.65
0.75
1.0
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.2
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
254
1.30
0.73
1.5
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
38
1.85
0.73
1.1
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
15
100
1.50
0.73
1.3
1.7
mmol/l
9.0
7.9
—
5
63
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
25
2.00
0.72
1.6
1.4
%
15.0
26.6
—
5
20
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
39
1.80
0.72
1.9
2.6
—
—
—
0
0
(3039000) Anion gap in Blood
37
291
1.28
0.71
6.6
10.8
mmol/l
11.8
11.3
0.45
37
257
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
41
1.71
0.70
1.1
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
37
292
1.27
0.69
6.6
10.7
mmol/l
104.5
105.3
0.54
37
258
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
62
519
1.20
0.69
1.5
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
42
1.67
0.68
6.0
3.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
110
1.46
0.68
1.3
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
59
1.53
0.68
1.8
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
127
1.42
0.68
4.2
4.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
351
0.77
0.67
1.4
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
94
1.49
0.66
1.2
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
41
331
1.24
0.65
1.4
1.6
—
—
—
0
0
(4035726)
136
1222
1.12
0.62
1.5
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.4
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
334
1.23
0.61
1.5
1.4
ug/g
208.3
273.6
1.02
24
198
(3051101) Glucose [Moles/volume] in Cord blood
0
21
0.00
0.60
0.0
5.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
21
0.00
0.60
0.0
1.9
—
1.2
—
0
21
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
166
1.33
0.58
2.0
2.4
umol/l
5.0
6.9
0.49
16
127
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
86
754
1.15
0.58
1.5
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
300
1.24
0.58
1.2
1.6
e6/l
263.6
678.7
0.54
28
248
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
300
1.24
0.58
1.2
1.5
e6/l
3.9
8.3
0.77
26
236
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
17
123
1.39
0.58
1.6
2.0
mg/l
9.8
20.9
—
5
40
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
298
0.77
0.58
1.1
2.3
nmol/l
0.8
0.8
0.03
17
246
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
40
328
1.22
0.57
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.4
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.4
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
54
1.48
0.57
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
54
1.48
0.57
1.4
2.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
54
1.48
0.57
1.3
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
292
1.24
0.57
3.1
2.4
ug/min
360.5
148.1
0.55
23
180
(3006653) Thiamine [Moles/volume] in Blood
10
65
1.54
0.55
1.0
1.2
nmol/l
145.8
132.0
—
10
65
(1002224) Polysomnography panel
51
601
0.84
0.55
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
82
1.47
0.54
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
9
61
1.48
0.53
1.2
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
62
1.45
0.53
1.1
1.0
%
75.7
87.8
—
9
46
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
91
1.43
0.53
1.5
1.5
—
62.5
—
0
11
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
66
1.52
0.52
1.1
1.0
miu/ml
2101.8
1617.8
—
10
66
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
63
1.43
0.52
1.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
242
1.24
0.51
1.4
2.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
41
1.46
0.50
1.0
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
51
592
0.86
0.48
1.4
1.7
mg/l
2.3
4.1
0.98
37
402
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.2
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
57
494
1.16
0.47
2.4
3.7
u/ml
57.5
8000.6
0.83
51
430
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
47
1.49
0.47
1.3
2.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
14
102
1.38
0.47
2.1
2.4
ml
658.1
541.9
—
9
67
(3051611) Lipemic interference index of Serum or Plasma
17
129
1.32
0.45
3.2
3.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
50
1.40
0.45
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
220
0.77
0.45
1.6
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
16
121
1.33
0.44
1.0
1.0
mg/l
295.9
291.1
0.11
16
109
(3048879) Bone marrow aspiration report
5
31
1.61
0.43
1.0
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
57
1.41
0.42
1.3
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
57
1.41
0.42
1.3
1.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
58
1.38
0.41
6.3
13.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
16
0.00
0.41
0.0
15.5
—
—
—
0
0
(4281824)
12
161
0.74
0.41
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
517
5347
0.95
0.40
2.9
2.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
249
0.80
0.40
1.4
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
75
673
1.12
0.40
1.4
1.5
—
—
—
0
0
(44806420)
5
35
1.43
0.39
1.8
2.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
151
1.26
0.38
1.2
1.4
nmol/l
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
37
1.35
0.37
1.4
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
105
967
1.09
0.36
2.0
2.2
nmol/l
13.1
13.1
0.00
93
852
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
77
0.65
0.35
1.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
108
1.30
0.35
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
124
0.72
0.35
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
45
1.33
0.33
2.8
2.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
127
1.26
0.33
1.6
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
137
1.24
0.32
1.1
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
267
1.16
0.31
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
267
1.16
0.31
1.5
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
52
1.35
0.31
1.6
2.2
ug/l
18.8
17.6
—
7
44
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
93
1.29
0.30
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
245
2346
1.05
0.29
2.7
2.8
ug/l
0.7
0.8
0.42
165
1454
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
110
0.73
0.29
1.9
1.4
g/l
0.9
1.0
—
8
110
(3044242) Glucose [Moles/volume] in Arterial blood
8
62
1.29
0.28
1.9
2.6
—
—
—
0
0
(4094501)
31
353
0.88
0.27
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
401
3893
1.04
0.27
1.5
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
15
182
0.82
0.26
1.1
1.4
mmol/l
5.4
7.4
—
8
132
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
74
1.22
0.25
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
37
330
1.12
0.25
4.4
4.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
75
1.20
0.25
1.6
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
9
75
1.20
0.25
1.4
1.3
u/l
15.1
10.4
—
9
67
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
32
360
0.89
0.24
1.5
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
14
115
1.22
0.23
1.1
1.2
nmol/l
2.1
1.6
0.69
14
107
(3011288) Drugs identified in Urine by Screen method
34
380
0.89
0.23
1.6
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
26
296
0.88
0.23
1.5
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
20
171
1.17
0.23
1.2
1.4
nmol/l
—
0.6
—
0
12
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
39
1.28
0.23
1.2
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
162
1.17
0.23
2.1
2.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
15
125
1.20
0.22
2.7
2.7
mg/l
429.7
22.1
—
9
91
(3022475) Manganese [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
33
296
1.12
0.21
1.6
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
8.6
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
154
1.17
0.21
1.1
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
6
49
1.23
0.20
1.3
2.3
—
2299.9
—
0
29
(3023511) Choriogonadotropin [Units/volume] in Urine
32
290
1.11
0.18
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
91
1.21
0.17
3.5
3.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
63
1.11
0.17
1.7
1.3
—
60.9
—
0
11
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
70
1.14
0.16
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
71
1.13
0.16
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
158
1526
1.04
0.16
4.8
4.2
%
32.4
32.4
0.02
115
1019
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
78
0.77
0.15
1.0
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
45
420
1.07
0.15
1.4
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
89
0.79
0.14
2.3
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
96
0.83
0.13
1.0
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
13
113
1.15
0.13
1.4
1.3
mmol/l
6.0
6.7
0.39
13
105
(40768441) Liver Pathology biopsy report
11
94
1.17
0.13
1.2
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
15
169
0.89
0.12
3.4
2.4
mmol/l
4.0
4.1
0.42
15
164
(3035285) Chloride [Moles/volume] in Venous blood
15
169
0.89
0.12
3.4
2.4
mmol/l
103.8
105.5
0.75
15
164
(3023323) Follitropin [Units/volume] in Serum or Plasma
75
717
1.05
0.12
1.3
1.4
iu/l
24.5
28.4
0.55
63
614
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
133
1.13
0.12
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
278
1.08
0.12
3.4
3.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
168
0.89
0.11
3.4
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
37
394
0.94
0.11
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
362
0.94
0.10
1.5
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
154
1.10
0.10
1.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
44
1.14
0.10
3.4
2.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
361
0.94
0.10
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
361
0.94
0.10
1.5
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
176
0.91
0.09
1.1
1.1
u/ml
1.7
5.9
—
5
64
(3044007) Cell count panel - Peritoneal fluid
5
48
1.04
0.09
1.4
2.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
48
1.04
0.09
1.2
1.1
g/l
—
0.2
—
0
5
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
26
243
1.07
0.08
1.0
1.1
iu/ml
7.8
2200.5
—
6
59
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
234
1.07
0.08
1.1
1.1
u/ml
0.9
1.2
0.27
14
98
(3000764) Benzodiazepines [Presence] in Urine
57
549
1.04
0.08
1.4
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
57
550
1.04
0.07
1.4
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
77
1.04
0.07
1.4
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
81
0.86
0.07
1.4
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
84
0.83
0.07
2.1
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
118
1.10
0.07
4.7
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
56
541
1.04
0.07
1.4
2.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
99
1.11
0.06
2.9
1.9
%
10.6
11.0
0.09
11
99
(3028300) Cannabinoids [Presence] in Urine
57
552
1.03
0.06
1.4
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
53
513
1.03
0.06
1.4
1.5
mu/l
281.9
303.9
0.25
46
468
(3005033) Fetal Nuchal fold Thickness US
28
294
0.95
0.06
1.5
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
188
1.06
0.05
1.2
2.3
—
4.7
—
0
6
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
336
1.04
0.05
1.8
1.9
iu/l
5.4
4.6
0.27
13
123
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
303
0.96
0.05
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
52
505
1.03
0.05
1.3
2.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
29
278
1.04
0.04
1.1
1.1
u/ml
1.3
2.0
0.31
15
109
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
160
1.06
0.04
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
51
523
0.97
0.04
1.4
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
371
0.97
0.03
1.2
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
24
231
1.04
0.02
1.3
1.4
nmol/l
0.2
0.4
1.28
18
186
(3003740) Influenza virus B Ag [Presence] in Specimen
23
239
0.96
0.02
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
23
239
0.96
0.02
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
719
1.02
0.02
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
402
1.02
0.01
1.3
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
235
2340
1.00
0.01
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
164
1.04
0.00
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
184
1.03
0.00
1.2
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
304
1.02
0.00
3.8
3.5
mg/l
31.9
26.9
0.42
22
192
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
96
954
1.01
0.00
1.7
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
245
1.02
0.00
1.1
1.1
u/ml
1.4
6.3
3.80
16
121
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
97
1.03
0.00
1.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.1
—
7.9
—
0
8
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
1.9
—
0
8
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
65
0.92
0.00
1.5
2.9
u/l
199.7
193.3
—
6
65
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
340.6
—
0
5
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
530
1.00
0.00
1.7
1.8
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.4
—
0
6
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
8
86
0.93
0.00
1.3
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
50
1.00
0.00
1.6
1.6
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
368.4
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
62
0.97
0.00
2.2
2.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
75
0.93
0.00
7.0
7.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
1.0
1.3
nmol/l
35.4
29.7
—
6
50
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
14.0
—
0
9
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
73
0.96
0.00
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
76
0.92
0.00
1.7
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
86
0.93
0.00
1.3
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_MONOARTHRITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MONOARTHRITIS | 1.23 [1.09, 1.39] | < 0.001 |
| Birth year | 0.997 [0.99, 1.0] | 0.419 |
During the follow-up period (1.1.1998 — 31.12.2019), 544 out of 3892 females with M13_MONOARTHRITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MONOARTHRITIS | 1.29 [1.12, 1.48] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.151 |
During the follow-up period (1.1.1998 — 31.12.2019), 540 out of 3094 males with M13_MONOARTHRITIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_MONOARTHRITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.127% | 0.331% |
| 5 | 0.767% | 1.819% |
| 10 | 1.901% | 4.276% |
| 15 | 3.597% | 8.309% |
| 20 | 6.664% | 13.939% |
Relationships between endpoints
↥Index endpoint: M13_MONOARTHRITIS – Monoarthritis, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data